Daiwa Securities Group Inc. - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 130 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$9
-18.2%
1940.0%0.00%
Q2 2023$11
+57.1%
1940.0%0.00%
Q1 2023$7
+40.0%
1940.0%0.00%
Q4 2022$5
-99.9%
194
+17.6%
0.00%
Q3 2022$5,000
-16.7%
1650.0%0.00%
Q2 2022$6,0000.0%1650.0%0.00%
Q1 2022$6,000
+50.0%
1650.0%0.00%
Q4 2021$4,000
+33.3%
1650.0%0.00%
Q3 2021$3,000
+50.0%
165
+85.4%
0.00%
Q2 2021$2,0000.0%890.0%0.00%
Q1 2021$2,0000.0%890.0%0.00%
Q4 2020$2,000
-60.0%
89
-66.4%
0.00%
Q3 2020$5,000
+25.0%
2650.0%0.00%
Q2 2020$4,0000.0%2650.0%0.00%
Q1 2020$4,000
-20.0%
2650.0%0.00%
Q4 2019$5,000
-16.7%
265
-10.5%
0.00%
Q3 2019$6,0000.0%2960.0%0.00%
Q2 2019$6,000
+20.0%
296
+16.5%
0.00%
Q1 2019$5,0000.0%2540.0%0.00%
Q4 2018$5,0000.0%2540.0%0.00%
Q3 2018$5,000
+25.0%
2540.0%0.00%
Q2 2018$4,000
-20.0%
2540.0%0.00%
Q1 2018$5,0002540.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$3,649,6053.75%
SHAKER INVESTMENTS LLC/OH 81,287$2,277,6621.41%
Mesirow Institutional Investment Management, Inc. 374,414$10,491,0801.38%
OBERWEIS ASSET MANAGEMENT INC/ 134,000$3,754,6800.80%
Portolan Capital Management 270,791$7,587,5640.75%
Hillsdale Investment Management Inc. 172,238$4,826,1090.41%
Capital Impact Advisors, LLC 14,669$411,0250.40%
Watershed Asset Management, L.L.C. 9,555$267,7310.34%
Quantedge Capital Pte Ltd 35,153$984,9870.33%
FEDERATED HERMES, INC. 3,284,217$92,023,7600.25%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders